Costales Jaime A, Sánchez-Gómez Amaya, Silva-Aycaguer Luis C, Cevallos William, Tamayo Susana, Yumiseva César A, Jacobson Jerry O, Martini Luiggi, Carrera Caty A, Grijalva Mario J
Center for Infectious Disease Research, Pontificia Universidad Católica del Ecuador, Quito, Ecuador; Pan American Health Organization, Quito, Ecuador; National School of Public Health, Havana, Cuba; National STI/HIV-AIDS Program, Ministry of Public Health, Quito, Ecuador; Pan-American Health Organization, Bogotá, Colombia; Instituto Nacional de Salud Pública e Investigación (INSPI), Guayaquil, Ecuador; Biomedical Center, Central University of Ecuador, Quito, Ecuador; Department of Biomedical Sciences, Tropical Disease Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio.
Center for Infectious Disease Research, Pontificia Universidad Católica del Ecuador, Quito, Ecuador; Pan American Health Organization, Quito, Ecuador; National School of Public Health, Havana, Cuba; National STI/HIV-AIDS Program, Ministry of Public Health, Quito, Ecuador; Pan-American Health Organization, Bogotá, Colombia; Instituto Nacional de Salud Pública e Investigación (INSPI), Guayaquil, Ecuador; Biomedical Center, Central University of Ecuador, Quito, Ecuador; Department of Biomedical Sciences, Tropical Disease Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio
Am J Trop Med Hyg. 2015 Apr;92(4):807-10. doi: 10.4269/ajtmh.14-0562. Epub 2015 Feb 9.
A nationwide survey was conducted to obtain an estimate of Chagas disease prevalence among pregnant women in Ecuador. As part of a national probability sample, 5,420 women seeking care for delivery or miscarriage at 15 healthcare facilities were recruited into the study. A small minority of participants reported knowing about Chagas disease or recognized the vector. A national seroprevalence of 0.1% (95% confidence interval [95% CI] = 0.0-0.2%) was found; cases were concentrated in the coastal region (seroprevalence = 0.2%; 95% CI = 0.0-0.4%). No cases of transmission to neonates were identified in the sample. Seropositive participants were referred to the National Chagas Program for evaluation and treatment. Additional studies are necessary to determine if areas of higher prevalence exist in well-known endemic provinces and guide the development of a national strategy for elimination of mother-to-child transmission of Chagas disease in Ecuador.
在厄瓜多尔开展了一项全国性调查,以估算孕妇中恰加斯病的患病率。作为全国概率样本的一部分,在15家医疗机构寻求分娩或流产护理的5420名妇女被纳入研究。少数参与者表示了解恰加斯病或认识其传播媒介。全国血清阳性率为0.1%(95%置信区间[95%CI]=0.0-0.2%);病例集中在沿海地区(血清阳性率=0.2%;95%CI=0.0-0.4%)。样本中未发现新生儿感染病例。血清阳性参与者被转介到国家恰加斯病项目进行评估和治疗。有必要开展更多研究,以确定在知名的流行省份是否存在患病率较高的地区,并指导制定消除厄瓜多尔恰加斯病母婴传播的国家战略。